Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18. (Q37045421)
Jump to navigation
Jump to search
scientific article published on 28 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18. |
scientific article published on 28 June 2016 |
Statements
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18 (English)
Richard S Finn
John P Crown
Johannes Ettl
Marcus Schmidt
Istvan Lang
Tamas Pinter
Katalin Boer
Ravindranath Patel
Sophia Randolph
Sindy T Kim
Xin Huang
Patrick Schnell
Sashi Nadanaciva
Cynthia Huang Bartlett
Dennis J Slamon